Dr. Laura Gonzalez, Arizona State University (IMAGE)

Arizona State University

Dr. Laura Gonzalez, Arizona State University

Caption

For Biodesign Institute postdoctoral researcher Dr. Laura Gonzalez, who was lead author of the study, it was important to correlate cell studies with patients in the clinic. The team found a drug resistance signature that predicted the early relapse of breast cancer for women taking tamoxifen in two different clinical cohorts.

Credit

Biodesign Institute at Arizona State University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.